IDXX - IDEXX LABORATORIES INC /DE

569.01
-14.050   -2.469%

Share volume: 577,942
Last Updated: 04-21-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances: 0.23%

PREVIOUS CLOSE
CHG
CHG%
$583.06
-14.05
-0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
56%
Profitability 81%
Dept financing 25%
Liquidity 5%
Performance 52%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-3.43%
1 Month
-1.64%
3 Months
-17.66%
6 Months
-10.22%
1 Year
34.97%
2 Year
18.65%
Key data
Stock price
$569.01
P/E Ratio 
50.99
DAY RANGE
$567.31 - $592.51
EPS 
$13.17
52 WEEK RANGE
$424.48 - $769.98
52 WEEK CHANGE
$33.37
MARKET CAP 
54.022 B
YIELD 
N/A
SHARES OUTSTANDING 
79.624 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
08-04-2025
BETA 
0.89
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$473,728
AVERAGE 30 VOLUME 
$500,421
Company detail
CEO: Jonathan J. Mazelsky
Region: US
Website: idexx.com
Employees: 10,800
IPO year: 1991
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances
Sector: Manufacturing

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for companion animal veterinary, livestock and poultry, dairy, and water testing markets. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides veterinary diagnostic products, including instruments, consumables, and rapid assay test kits.

Recent news